Almirall is a pharmaceutical company dedicated to providing valuable medications to patients all over the world. With a mission to improve health and wellbeing, Almirall focuses on developing innovative solutions for various skin conditions such as psoriasis, actinic keratosis, atopic dermatitis, acne, onychomycosis, and alopecia areata. Additionally, they specialize in the treatment of skin cancer and offer products for different types of skin.

Beyond dermatology, Almirall is committed to addressing other areas of healthcare, including spasticity in multiple sclerosis, chronic pain, diabetes, cardiovascular issues, back pain, allergies, and digestive disorders. They prioritize patient care and encourage communication regarding any adverse effects experienced. Almirall is dedicated to research and development, with a robust pipeline of clinical trials and collaborations.

They are also passionate about environmental sustainability and ensure transparency in their operations. Almirall's products are available worldwide, with a presence in numerous countries including France, Germany, Italy, Spain, and the United States